Announced Wed, 8 Jul · 17:45 IST
Compliance certificate for share dematerialisation submitted for Q1 FY27
Compliance View source PDF
KILITCH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.5%1-day move
₹184.00
prior close
₹184.98
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+0.5-2.2-4.4-1.8-0.5-3.8————
Up moveDown movePending
AI summary
Kilitch Drugs has submitted to NSE and BSE a certificate from its registrar MUFG Intime India for the quarter ended 30 June 2026. The certificate confirms that all share certificates received for dematerialisation were processed and listed on stock exchanges, and physical certificates were cancelled as per SEBI norms. This is a routine regulatory filing under Regulation 74(5) of the Depositories and Participants Regulations, 2018.
Likely market impact
Routine compliance filing with no material impact on shareholders or stock price.